Introduction
The novel coronavirus (COVID-19) has been identified as the cause of a severe acute respiratory syndrome, accounting for thousands of cases of severe pneumonia, respiratory failure and death globally (1). Whilst current management is largely supportive, a minority with cardio-circulatory instability secondary to acute cardiac injury, myocarditis, acute pulmonary embolism, or other complex conditions (2), require mechanical ventilation or extracorporeal membrane oxygenation.